Mylan "Clamps" Hicks passed away at the age of 23 from a gunshot wound Sunday morning in Calgary. In my entire career as being a journalist, those were the toughest words I've ever had to write ...

4. Biosimilars will fuel growth. Mylan likes the potential for its biosimilars. Rajiv Malik pointed to the company's recent submission for U.S. approval of a biosimilar to Herceptin.

After news broke that the price of EpiPen injectors has skyrocketed, the allergy medicine’s maker, Mylan, announced its intention to offer a generic version of the product, to be sold at half ...

We’ll send you a myFT Daily Digest email rounding up the latest US & Canadian companies news every morning. The doctor stood at the foot of my bed in London’s Whittington Hospital. “I don ...

CNBC's Jim Cramer fired back Thursday on comments from Mylan (MYL) CEO Heather Bresch about pricing of the auto-injection device EpiPen. "If you can get away with jacking things up and gouging it ...

Last month, Mylan Chairman Robert Coury challenged suitor Teva to either put up a formal bid or step aside and let his company proceed with its plan to pursue its own target, Perrigo. And he may ...